DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Benzoylecgonine is an investigational drug.
There have been 18 clinical trials for Benzoylecgonine. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2001.
The most common disease conditions in clinical trials are Cocaine-Related Disorders, Renal Insufficiency, and Substance-Related Disorders. The leading clinical trial sponsors are National Institute on Drug Abuse (NIDA), University of Pennsylvania, and Cincinnati MDRU.
Recent Clinical Trials for Benzoylecgonine
|Trial Of NS2359 For The Treatment of Cocaine Dependence||Saniona||Phase 2|
|Trial Of NS2359 For The Treatment of Cocaine Dependence||The Dana Foundation||Phase 2|
|Trial Of NS2359 For The Treatment of Cocaine Dependence||University of Pennsylvania||Phase 2|